Ir directamente a la navegación principal
Ir directamente a la búsqueda
Ir directamente al contenido principal
Clasificar por
Keyphrases
Latin America (LATAM)
100%
Latin American
100%
Caribbean
100%
Pharmacogenomics
100%
Barrier Perception
100%
Drug-gene
100%
Gene Pairs
100%
Cytochrome P450 2D6 (CYP2D6)
66%
Clinical Application
50%
Caribbean Countries
33%
Clinical Trials
33%
CYP2C19
33%
Thiopurines
33%
Tricyclic Antidepressants
33%
Gene Drug
33%
Latin American Countries
16%
Scientific Community
16%
Primary Barrier
16%
Pharmacogenetics
16%
Developing Countries
16%
Structured Survey
16%
Limited Information
16%
Cost-effectiveness
16%
Clopidogrel
16%
Caribbean Region
16%
Search Results
16%
Genomic Medicine
16%
Opioids
16%
Raising Awareness
16%
Potential Barrier
16%
Emergent Fields
16%
Mixed Population
16%
Fluoropyrimidine
16%
CYP3A5
16%
NUDT15
16%
Clinical Implementation
16%
Efavirenz
16%
Drug Pair
16%
Survey Results
16%
Clinical Community
16%
Tacrolimus
16%
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacogenomics
100%
CYP2D6
75%
Clinical Trial
50%
Biological Marker
50%
CYP2C19
50%
Mercaptopurine
50%
Tricyclic Antidepressant
50%
Pharmacogenetics
25%
Clopidogrel
25%
Tamoxifen
25%
Efavirenz
25%
Cytochrome P450 3A5
25%
Tacrolimus
25%
CYP2B6
25%
Fluoropyrimidine
25%
Neuroscience
Cytochrome P450 2D6
100%
Cytochrome P450 2C19
66%
Tricyclic Antidepressant
66%
Mercaptopurine
66%
Clopidogrel
33%
Tamoxifen
33%
Tacrolimus
33%
CYP2B6
33%
Cytochrome P450 3A5
33%
Efavirenz
33%
Fluoropyrimidine
33%
Biochemistry, Genetics and Molecular Biology
Pharmacogenomics
100%
CYP2D6
75%
Clinical Trial
50%
CYP2C19
50%
Mercaptopurine
50%
Genomics
25%
Pharmacogenetics
25%
Clopidogrel
25%
Awareness
25%
CYP2B6
25%
Digital Positive Youth Development
25%
CYP3A5
25%
Efavirenz
25%
Immunology and Microbiology
Pharmacogenomics
100%
Pharmacogenetics
25%
Awareness
25%
Tacrolimus
25%